Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances

Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq’s stockholders’ equity requirement, with the Nasdaq Hearings Panel granting the company’s request for continued listing subject to certain conditions. The Nasdaq compliance milestone removes one specific listing issue for Glucotrack as management continues its strategic transformation, although the company said it is still working toward full compliance with all applicable Nasdaq standards.